Koichi Mishima, None;
Naomi Mataki, None;
Michiko Yonahara, None;
Shinichiro Otani, None;
Hiroshi Sakai, None;
Atsuo Tomidokoro, None;
Makoto Aihara, Alcon Japan (F), Alconpharma (F), Allergan (R), AMO Japan (F), Canon (R), Carl Zeiss Meditec (R), CREWT medical systems (F), Glaukos (F), HOYA (C), Iridex (C), Ivantis (R), Kowa (F), LnnFocus (C), Nitten (R), Novaltispharma (F), Ono (F), Otsuka (F), Pfyzer (F), Santen (F), Senju (F), TOMEY (F), Wakamoto (F), Wakamoto (F);
Kazunori Miyata, AMO Japan (F), Ancon Japan (F), GSK (F), HOYA (F), Kissei (F), Kowa (R), MSD (R), Novartis (F), Otsuka (F), Pfyzer (R), Santen (F), Senju (F), Shionogi (F), TOMEY (R), wakamoto (F);
Aiko Iwase, Topcon (I);
Makoto Araie, Tocon (P)